Cytomegalovirus Infection after CD34+-Selected Hematopoietic Cell Transplantation
详细信息 查看全文
- 作者：Yao-Ting Huang1 ; Dionysios Neofytos1 ; 2 ; &dagger ; ; Julia Foldi1 ; Seong Jin Kim1 ; Molly Maloy3 ; Dick Chung1 ; Hugo Castro-Malaspina2 ; 3 ; Sergio A. Giralt2 ; 3 ; Esperanza Papadopoulos2 ; 3 ; Miguel-Angel Perales2 ; 3 ; Ann A. Jakubowski2 ; 3 ; Genovefa A. Papanicolaou1 ; 2 ; papanicg@mskcc.org" class="auth_mail" title="E-mail the corresponding author
- 关键词：Cytomegalovirus ; CMV viremia ; Epidemiology ; Hematopoietic cell transplantation ; T cell depletion
- 刊名：Biology of Blood and Marrow Transplantation
- 出版年：2016
- 出版时间：August 2016
- 年：2016
- 卷：22
- 期：8
- 页码：1480-1486
- 全文大小：599 K
文摘
- •
Cytomegalovirus viremia occurs commonly and early among CMV sero-positive T cell–depleted hematopoietic cell transplant recipients.
- •
Persistent viral replication despite antiviral treatment highlights the need for more effective and safe cytomegalovirus therapies.
- •
Cytomegalovirus recipient/donor serostatus did not have a significant impact on 1-year overall survival.